This guide examines the types of interventions that support successful reentry for adults with mental health conditions and/or substance use disorders who are leaving jail/prison.

This guide highlights strategies for behavioral health and housing providers to conduct outreach and engage with individuals experiencing homelessness, initiate use of behavioral health treatment as they wait to receive stable housing and retain them in their recovery efforts once housed.

This CDC Resource offers Community Preventive Services Task Force recommendations and evidence ratings on regulation of alcohol outlet density, taxes, dram shop liability, sales, electronic screening, and minor sales.

The Rx Pain Medications, Know the Options, Get the Facts is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management.

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine as part of medication-assisted treatment (MAT) for opioid use disorder.

Technical brief describes and compares four core management strategies to reduce psychiatric readmissions—length of stay for inpatient care, transition support services, short-term alternatives to psychiatric rehospitalization, and long-term approaches for reducing psychiatric rehospitalization—for patients at high risk of psychiatric readmission.

This fact sheet offers young adults information on living with psychosis. It discusses causes of psychosis, and approaches to treatment.

This brief defines drug addiction and discusses treatment approaches for combating it.

This brief discusses effective prevention and treatment strategies for opioid misuse and addiction.

This brief provides guidelines on prescribing Opioids for Pain.

This fact sheet developed by CDC’s National Institute for Occupational Safety and Health (NIOSH) helps employers understand the risk of opioid overdose and allows them to decide if they should establish a workplace naloxone availability and use program.

The purpose of this systematic review is to evaluate treatments for adults with schizophrenia.